Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Recs

0
Player Avatar clm5567 (67.37) Submitted: 9/15/2010 8:03:13 PM : Outperform Start Price: $38.10 COV Score: +22.77

This is a very strong company with very little debt. They are also leaders in the areas they serve.

Featured Broker Partners


Advertisement